Current Cancer Drug Targets

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Volume 22 , Issues 11, 2022

This journal supports open access

Back Journal Home

Volume 22, Issue 7, August 2022


Perspective

β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer

Pp: 537-540
Author: Muhammad Imran Qadir*, Muhammad Shahid Iqbal and Rimsha Khan
DOI: 10.2174/1568009622666220427121127
Published on: 31 May, 2022

Review Article

Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer

Pp: 541-559
Author: Kun Zheng, Suzhen Chen* and Xiaoyong Hu*
DOI: 10.2174/1568009622666220330194149
Published on: 23 May, 2022

Review Article

Pharmacological Inhibition of Exosome Machinery: An Emerging Prospect in Cancer Therapeutics

Pp: 560-576
Author: Saima Syeda, Kavita Rawat and Anju Shrivastava*
DOI: 10.2174/1568009622666220401093316
Published on: 09 June, 2022

Research Article

Modulation of ATP8B1 Gene Expression in Colorectal Cancer Cells Suggest its Role as a Tumor Suppressor

Pp: 577-590
Author: Saleh Althenayyan, Amal AlGhamdi, Mohammed H. AlMuhanna, Esra Hawsa, Dalal Aldeghaither, Jahangir Iqbal, Sameer Mohammad and Mohammad A. Aziz*
DOI: 10.2174/1568009622666220517092340
Published on: 19 May, 2022

Research Article

Silencing of FANCI Promotes DNA Damage and Sensitizes Ovarian Cancer Cells to Carboplatin

Pp: 591-602
Author: Yuqing Li, Yanan Zhang, Qi Yang, Xuantong Zhou, Yuanyuan Guo, Fang Ding, Zhihua Liu and Aiping Luo*
DOI: 10.2174/1568009622666220331091709
Published on: 23 May, 2022

Research Article

EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling

Pp: 603-616
Author: Yixiong Ren, Yonglong Hong, Wenting He, Yakun Liu, Wenge Chen, Sui Wen* and Moyi Sun*
DOI: 10.2174/1568009622666220411112312
Published on: 09 June, 2022

© 2022 Bentham Science Publishers | Privacy Policy